Latest news
Scholar Rock’s Apitegromab Filing Exposes the CMO Due Diligence Gap That Keeps Burning Sponsors - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 11 Aug 2026 07:39:19 GMTThe B-Cell Depletion Arms Race in CNS Autoimmune Trials Has a New Front-Runner — And It Rewrites the Regulatory Playbook - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 11 Aug 2026 07:34:19 GMTSionna’s SION-719 Misses Sweat Chloride Target in CF Study - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 11 Aug 2026 06:39:13 GMTOncoinvent publishes dosimetry data for Radspherin in peritoneal metastases - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 11 Aug 2026 06:39:13 GMTTenax Announces Phase 3 LEVEL Trial Topline Results for TNX-103 in PH-HFpEF - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 11 Aug 2026 06:34:18 GMTKodiak Sciences Enrolls First Patient in Phase 3 ALTO Trial of KSI-501 for Diabetic Macular Edema - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 11 Aug 2026 06:34:17 GMTEvaluating the Future of CAR-T Studies in Systemic Sclerosis - EMJEMJ · Tue, 11 Aug 2026 00:10:31 GMTDESTINY Trials May Reshape HER2-Positive Breast Cancer Care With T-DXd - CancerNetworkCancerNetwork · Mon, 10 Aug 2026 21:08:52 GMT